COST-UTILITY ANALYSIS OF LURASIDONE FOR THE TREATMENT OF SCHIZOPHRENIA IN CHINA

被引：0
|
作者：
Cao, D. [1 ]
Liu, J. [1 ,2 ]
Liu, J. [1 ,2 ]
He, X. [1 ]
Wu, J. [1 ]
机构：
[1] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China
[2] Sumitomo Pharma Suzhou Co Ltd, Shanghai, Peoples R China
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH33
引用
收藏
页码：S133 / S133
页数：1
相关论文
共 50 条
  • [21] Cost-utility analysis
    Brown, GC
    Brown, MM
    Sharma, S
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) : 625 - 626
  • [22] Cost-utility analysis of romiplostim for the treatment of chronic primary immune thrombocytopenia in China
    Luo, Yashuang
    Cheng, Wendi
    Fu, Yuyan
    Wang, Haode
    Wang, Haiyin
    INTRACTABLE & RARE DISEASES RESEARCH, 2024, 13 (03) : 157 - 164
  • [23] COST-UTILITY ANALYSIS
    NICHOLLS, A
    BRITISH MEDICAL JOURNAL, 1993, 307 (6913): : 1213 - 1213
  • [24] COST-EFFECTIVENESS ANALYSIS OF LURASIDONE AND OLANZAPINE IN THE TREATMENT OF SCHIZOPHRENIA
    Priyadarshini, M.
    Hay, J. W.
    VALUE IN HEALTH, 2016, 19 (03) : A188 - A189
  • [25] THE COST-UTILITY OF SOLIFENACIN IN THE TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER IN CHINA
    Fan, C.
    Liao, L.
    Wang, J.
    Zhang, H.
    Chen, B.
    Wu, J.
    VALUE IN HEALTH, 2016, 19 (03) : A129 - A129
  • [26] Regionalization of treatment for subarachnoid hemorrhage: A cost-utility analysis
    Bardach, NS
    Olson, SJ
    Smith, WS
    Johnston, SC
    STROKE, 2003, 34 (01) : 255 - 256
  • [27] Regionalization of treatment for subarachnoid hemorrhage - A cost-utility analysis
    Bardach, NS
    Olson, SJ
    Elkins, JS
    Smith, WS
    Lawton, MT
    Johnston, SC
    CIRCULATION, 2004, 109 (18) : 2207 - 2212
  • [28] Interpreting cost-utility analysis of prostate cancer treatment
    James B. Yu
    Nature Reviews Urology, 2013, 10 : 129 - 131
  • [29] COST-UTILITY ANALYSIS OF MULTIPLE SCLEROSIS TREATMENT IN THAILAND
    Chanatittarat, Chalakorn
    Chaikledkaew, Usa
    Prayoonwiwat, Naraporn
    Siritho, Sasitorn
    Pasogpakdee, Pakamas
    Apiwattanakul, Metha
    Riewpaiboon, Arthorn
    Thavorncharoensap, Montarat
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (06) : 584 - 592
  • [30] Interpreting cost-utility analysis of prostate cancer treatment
    Yu, James B.
    NATURE REVIEWS UROLOGY, 2013, 10 (03) : 129 - 131
12345